Position in NUVB
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$223,035,351
-$237,732,476 QoQ
Shares Held
51,989,593
+1.1% QoQ
Ownership
14.9%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NUVB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FMR LLC holds $49,682,018,247 across 354 Biotechnology names. NUVB ranks #52 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,579,166 | $4,823,808,652 | |
| 2 | ARGX |
Argenx SE
|
4,991,034 | $3,644,702,577 | |
| 3 | MRNA |
Moderna, Inc.
|
45,672,024 | $2,320,138,818 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
77,981,253 | $2,160,080,705 | |
| 5 | INSM |
INSMED Inc
|
13,160,167 | $2,151,950,504 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,556,637 | $1,843,957,869 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,152,242 | $1,206,553,046 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,518,192 | $1,173,015,865 |
All Filings in NUVB
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $223,035,351 | 51,989,593 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $460,767,827 | 51,424,981 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $187,110,752 | 50,570,474 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $99,526,658 | 51,039,313 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $89,054,635 | 50,599,225 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $120,459,620 | 45,285,572 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $66,957,013 | 29,238,871 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $84,160,060 | 28,821,939 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $100,962,958 | 27,737,077 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $39,457,294 | 26,130,659 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $43,797,786 | 32,684,916 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $58,807,003 | 32,670,558 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $54,232,999 | 32,670,482 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $50,931,771 | 26,526,965 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $66,862,796 | 29,849,463 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $103,307,499 | 31,885,031 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $166,209,303 | 31,598,727 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $269,161,338 | 31,666,040 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $319,373,927 | 32,130,174 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $303,947,954 | 32,647,471 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $337,372,971 | 32,284,495 | Shares | Defined | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||